Key result
Myocarditis and cardiomyopathy are linked to significantly higher CD117+ cell levels vs healthy controls.
Why the study?
The presence and quantification of CD117+ and CD90+ endogenous cardiac progenitor cells in healthy and diseased human hearts were not well characterized.
Observational (n=23)
Answers are grounded in this paper and cite their sources.
Endogenous cardiac progenitor cells (CD117+/CD90+) are present in the human heart and their numbers increase significantly in conditions like myocarditis and cardiomyopathy.
We aimed to identify and quantify CD117+ and CD90+ endogenous cardiac progenitor cells in human healthy and diseased hearts. We hypothesize that these cells perform a locally acting, contributing function in overcoming medical conditions of the heart by endogenous means. Human myocardium biopsies were obtained from 23 patients with the following diagnoses: Dilatative cardiomyopathy (DCM), ischemic cardiomyopathy (ICM), myocarditis and controls from healthy cardiac patients. High-resolution scanning microscopy of the whole slide enabled a computer-based immunohistochemical quantification of CD117 and CD90. Those signals were evaluated by Definiens Tissue Phenomics® Technology. Co-localization of CD117 and CD90 was determined by analyzing comparable serial sections. CD117+/CD90+ cardiac cells were detected in all biopsies. The highest expression of CD90 was revealed in the myocarditis group. CD117 was significantly higher in all patient groups, compared to healthy specimens (*p < 0.05). The highest co-expression was found in the myocarditis group (6.75 ± 3.25 CD90+CD117+ cells/mm²) followed by ICM (4 ± 1.89 cells/mm²), DCM (1.67 ± 0.58 cells/mm²) and healthy specimens (1 ± 0.43 cells/mm²). We conclude that the human heart comprises a fraction of local CD117+ and CD90+ cells. We hypothesize that these cells are part of local endogenous progenitor cells due to the coexpression of CD90 and CD117. With novel digital image analysis technologies, a quantification of the CD117 and CD90 signals is available. Our experiments reveal an increase of CD117 and CD90 in patients with myocarditis.
No takes yet. Share an insight, caveat, or question.
Gerisch et al. (2018) conducted an observational in Myocarditis and Cardiomyopathy (n=23). Myocarditis and Cardiomyopathy vs. Healthy controls was evaluated on CD117 and CD90 expression and co-localization (p=< 0.05). Myocarditis and cardiomyopathy were associated with higher levels of CD117+ cells compared to healthy controls, with highest co-expression in myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: